SOAT1 and diffuse large B-cell lymphoma: Relatedly, activated JAK/STAT signaling is observed in EBV+ diffuse large B-cell lymphoma [82], the Hodgkin lymphoma Reed-Sternberg tumor cell [58], post-transplant lymphoproliferative disease [83–85] and plasmablastic lymphoma [86].